Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brandon Swed
Observed names:
B. Swed,
B., Swed,
Brandon L. Swed
Institutions:
NewYork–Presbyterian Hospital,
Cornell University,
Weill Cornell Medicine
Observed institutions:
NewYork–Presbyterian Hospital,
NewYork–Presbyterian Brooklyn Methodist Hospital,
Cornell University,
Weill Cornell Medicine,
Weill Cornell Medical Center,
University of Pennsylvania
show all 6
ORCID:
0000-0001-9441-7912
Observed ORCID:
0000-0001-9441-7912
OpenAlex ID:
A5008513862
COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study
2020
·
Gagandeep Brar
, Laura C. Pinheiro
, et al.
·
Journal of Clinical Oncology
·
136
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
2023
·
Pashtoon Murtaza Kasi
, Manuel Hidalgo
, et al.
·
Oncogene
·
54
PDF
Neoadjuvant botensilimab plus balstilimab in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial.
2024
·
Pashtoon Murtaza Kasi
, Mehraneh D. Jafari
, et al.
·
Journal of Clinical Oncology
·
25
PDF
Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience
2021
·
Brandon Swed
, Omar Gandarilla
, et al.
·
Case Reports in Hepatology
·
23
PDF
Long COVID in Cancer: A Matched Cohort Study of 1-year Mortality and Long COVID Prevalence Among Patients With Cancer Who Survived an Initial Severe SARS-CoV-2 Infection
2023
·
Olivia Fankuchen
, Jennifer Lau
, et al.
·
American Journal of Clinical Oncology
·
12
PDF
False-Positive Liquid Biopsy Assays Secondary to Overlapping Aberrant Methylation from Non-Cancer Disease States
2023
·
Areeb Lutfi
, Maaz Khan Afghan
, et al.
·
Case Reports in Oncology
·
11
Favorable response to second-line atezolizumab and bevacizumab following progression on nivolumab in advanced hepatocellular carcinoma: A case report demonstrating that anti-VEGF therapy overcomes resistance to checkpoint inhibition
2021
·
Brandon Swed
, Kara Ryan
, et al.
·
Medicine
·
11
Targeting HER2/neu Oncogene Overexpression With Ado-Trastuzumab Emtansine in the Treatment of Metastatic Salivary Gland Neoplasms: A Single-Institution Experience
2019
·
Brandon L. Swed
, Roger B. Cohen
, et al.
·
JCO Precision Oncology
·
10
8MO Neoadjuvant botensilimab (BOT) plus balstilimab (BAL) in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial
2024
·
P.M. Kasi
, M.D. Jafari
, et al.
·
Annals of Oncology
·
7
PDF
Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancers
2023
·
Frederic Karim
, Adina Amin
, et al.
·
Cancers
·
5
PDF
Advanced Gastric Adenocarcinoma Presenting With Shoulder Pain and Diplopia
2025
·
Omar Gandarilla
, Aashi Saraf
, et al.
·
Cureus
·
1
PDF
Abstract B005: Geospatial and structural determinants of colorectal cancer burden among Black patients in Brooklyn: A composite score approach including food insecurity
2025
·
Omar Gandarilla Cuellar
, Brandon Swed
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
Supplementary Material for: False-positive liquid biopsy assays secondary to overlapping aberrant methylation from non-cancer disease states
2023
·
A., Lutfi
, M.K., Afghan
, et al.
·
Figshare
ORIENT-32 trial: sintilimab + bevacizumab biosimilar as a promising combination therapy in advanced hepatocellular carcinoma
2021
·
Brandon Swed
, Omar Gandarilla
, et al.
·
Digestive Medicine Research
Abstract S10-01: COVID-19 severity and outcomes in hospitalized patients with cancer at a New York City tertiary medical center: A matched cohort study
2020
·
Gagandeep Brar
, Laura C. Pinheiro
, et al.
·
Clinical Cancer Research
COVID-19 severity and outcomes inhospitalized patients with cancer at a New York Citytertiary medical center: A matched cohort study
2020
·
Gagandeep Brar
, Laura C. Pinheiro
, et al.
·
Clinical Cancer Research
Show more works
View as search
Works count:
16
Citation count:
295
H-index:
8
I10-index:
8
Year
Topic
Type